Your browser doesn't support javascript.
loading
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.
Servellita, Venice; Morris, Mary Kate; Sotomayor-Gonzalez, Alicia; Gliwa, Amelia S; Torres, Erika; Brazer, Noah; Zhou, Alicia; Hernandez, Katherine T; Sankaran, Madeline; Wang, Baolin; Wong, Daniel; Wang, Candace; Zhang, Yueyuan; Reyes, Kevin R; Glasner, Dustin; Deng, Xianding; Streithorst, Jessica; Miller, Steve; Frias, Edwin; Rodgers, Mary; Cloherty, Gavin; Hackett, John; Hanson, Carl; Wadford, Debra; Philip, Susan; Topper, Scott; Sachdev, Darpun; Chiu, Charles Y.
Affiliation
  • Servellita V; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Morris MK; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
  • Sotomayor-Gonzalez A; Viral and Rickettsial Disease Laboratory, California Department of Public Health, Richmond, CA, USA.
  • Gliwa AS; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Torres E; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
  • Brazer N; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Zhou A; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
  • Hernandez KT; Color Genomics, Inc., Burlingame, CA, USA.
  • Sankaran M; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Wang B; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
  • Wong D; Color Genomics, Inc., Burlingame, CA, USA.
  • Wang C; San Francisco Department of Public Health, San Francisco, CA, USA.
  • Zhang Y; San Francisco Department of Public Health, San Francisco, CA, USA.
  • Reyes KR; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Glasner D; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
  • Deng X; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Streithorst J; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
  • Miller S; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Frias E; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
  • Rodgers M; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Cloherty G; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
  • Hackett J; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Hanson C; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
  • Wadford D; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Philip S; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
  • Topper S; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Sachdev D; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA, USA.
  • Chiu CY; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Nat Microbiol ; 7(2): 277-288, 2022 02.
Article de En | MEDLINE | ID: mdl-35013591

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / COVID-19 / Vaccin BNT162 / Anticorps antiviraux Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: America do norte Langue: En Journal: Nat Microbiol Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / COVID-19 / Vaccin BNT162 / Anticorps antiviraux Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: America do norte Langue: En Journal: Nat Microbiol Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique